Protara Therapeutics

About:

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

Website: https://protaratx.com/

Top Investors: RA Capital Management, Catalio Capital Management, Woodline Partners, Red Cedar Ventures, Boxer Capital

Description:

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. The Protara team prioritizes creativity, diverse perspectives, and tenacity to expedite their goal of bringing life-changing therapies to people with limited treatment options.